Table 3

Subgroup analysis on pooled ORs for the association between cigarette smoking and nasopharyngeal carcinoma

SubgroupNo. of studiesEffect estimate (95% CI)Heterogeneity
I2 , p
Egger’s test p Value Adjusted for publication bias
Smoking status
 Ever smokers191.56 (1.32 to 1.83)66.8%, <0.010.291.56 (1.32–1.84)
Current smokers111.59 (1.35 to 1.89)32.5%, 0.140.10
 Former smokers101.36 (1.15 to 1.61)2.3%, 0.420.97
Design
 Case–control
 Current smokers81.67 (1.06 to 2.61)22.6%, 0.250.58
 Former smokers81.45 (1.21 to 1.73)0.0%, 0.700.98
Cohort
 Current smokers32.19 (1.02 to 4.72)65%, 0.060.16
 Former smokers20.87 (0.54 to 1.41)0.0%, 0.37
Pack-years
 <3071.34 (1.13 to 1.58)0.0%, 0.730.54
 ≥3062.03 (1.57 to 2.61)0.0%, 0.45<0.011.80 (1.37–2.36)
Age at onset of smoking (years)
 <1851.78 (1.41 to 2.25)0.0%, 0.940.46
 ≥1851.28 (1.00 to 1.64)0.0%, 0.860.93
Incidence rate
 Low51.68 (1.36 to 2.07)0.0%, 0.840.64
 Intermediate101.59 (1.21 to 2.09)78.8%, <0.010.29
 High41.27 (1.05 to 1.53)0.0%, 0.520.63
Gender
 Man51.36 (1.15 to 1.60)0.0%, 0.680.48
 Woman21.58 (0.99 to 2.53)0.0%, 0.64
Histological type
 Differentiated52.34 (1.77 to 3.09)0.0%, 0.720.64
 Undifferentiated41.15 (0.90 to 1.46)0.0%, 0.020.28
Adjustment
 Adjusted131.55 (1.26 to 1.91)75.4%, <0.010.33
 Unadjusted61.57 (1.27 to 1.93)0.0%, 0.680.93